Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
IVA similar filings
- 21 May 24 Inventiva reports 2024 First Quarter Financial Information1 and provides a corporate update
- 16 May 24 Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
- 13 May 24 Current report (foreign)
- 13 May 24 Current report (foreign)
- 27 Mar 24 Inventiva reports its 2023 full-year results
- 18 Mar 24 Current report (foreign)
- 7 Mar 24 Inventiva announces that screening in the NATiV3, Phase III, clinical trial evaluating lanifibranor in NASH has resumed
Filing view
External links